Home > Field of Cooperation > Health Research > Integrated application of human and pathogen genomic information for improvement of treatment outcome and control of drug-resistance in Asian tuberculosis patients
Integrated application of human and pathogen genomic information for improvement of treatment outcome and control of drug-resistance in Asian tuberculosis patients |
| Principal Investigator / Affiliation | Katsushi Tokunaga (Director) / National Center for Global Health and Medicine (NCGM)  Japan |
|---|---|
Surakameth Mahasirimongkol (Medical Doctor) / Ministry of Public Health  Thailand |
|
Ma. Cecilia Ama (Head) / Research Institute for Tropical Medicine  Philippines |
|
Rika Yuliwulandari (Dean) / YARSI University  Indonesia |
|
| Year Adopted | 2019 |
| Research Period | |
| General Description of the Research Project | The integrated analysis of human and Mycobacterium tuberculosis aims to identify genomic biomarkers associated with efficacy of anti-tuberculosis (TB) treatment, risk of adverse drug reactions (ADRs), systemic exposure of anti-TB drugs, and occurrence of drug–resistance strain of M. tuberculosis. Biomarkers will be used for establishment of precision medicine for successful treatment and reduction of drug resistance in Asian TB patients. |
| Photo Gallery | |
| Reports | |
| Links |
Researchers
| Principal Investigator / Country of Research Team | 
Katsushi Tokunaga Japan
Surakameth Mahasirimongkol Thailand
Ma. Cecilia Ama the Philippines |
||
|---|---|---|---|
| Project members / Country of Research Team |
|
